FinancialContent is the trusted provider of stock market information to the media industry.
DIAGNOS Announces Grant of Stock Options
BROSSARD, QUEBEC, CANADA--(Marketwire - Feb. 28, 2012) - DIAGNOS inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE:ADK), a leader in the use of artificial intelligence and advanced knowledge extraction techniques, announces that, on February 27, 2012, the Board of Directors has approved a grant of 90,000 stock options to three officers of the Corporation under the terms of the stock option plan of the Corporation approved by the Shareholders in September 2008.
The exercise price of these options has been established at C$0.26 per share. Grants of stock options vest at the rate of 33.33% per year, commencing with the first anniversary of the grant. The expiry date to which these options can be exercised has been fixed to February 26, 2017.
Founded in 1998, DIAGNOS is a publicly traded Canadian corporation with a mission to commercialize technologies combining contextual imaging and traditional data mining thereby improving decision making processes. DIAGNOS offers products, services, and solutions to clients in a variety of fields including natural resources, healthcare, and entertainment.
For further information, please visit our website at www.diagnos.com or the SEDAR website at www.sedar.com.Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here